Zions Bancorporation, N.A. Biogen Inc. Transaction History

Zions Bancorporation, N.A.

$1.24 Billion
Q2 2024

A detailed history of Zions Bancorporation, N.A. transactions in Biogen Inc. stock. As of the latest transaction made, Zions Bancorporation, N.A. holds 101 shares of BIIB stock, worth $19,061. This represents 0.0% of its overall portfolio holdings.

Number of Shares

101

Previous 144 29.86%

Holding current value

$19,061

Previous $31,000 25.81%

% of portfolio

0.0%

Previous 0.0%

22 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Aug 08, 2024	SELL	$190.52 - $236.72 $8,192 - $10,178	-43 Reduced 29.86%	101 $23,000
Q1 2024 May 14, 2024	SELL	$212.02 - $267.71 $4,028 - $5,086	-19 Reduced 11.66%	144 $31,000
Q4 2023 Feb 12, 2024	BUY	$222.59 - $267.94 $1,558 - $1,875	7 Added 4.49%	163 $42,000
Q3 2023 Nov 07, 2023	SELL	$253.3 - $285.89 $506 - $571	-2 Reduced 1.27%	156 $40,000
Q1 2023 May 10, 2023	SELL	$256.56 - $292.34 $1,282 - $1,461	-5 Reduced 3.07%	158 $43,000
Q4 2022 Feb 10, 2023	SELL	$252.44 - $306.72 $3,029 - $3,680	-12 Reduced 6.86%	163 $45,000
Q3 2022 Nov 08, 2022	SELL	$194.69 - $268.46 $194 - $268	-1 Reduced 0.57%	175 $47,000
Q2 2022 Aug 05, 2022	SELL	$187.54 - $223.02 $9,377 - $11,151	-50 Reduced 22.12%	176 $36,000
Q1 2022 May 13, 2022	BUY	$193.77 - $244.14 $5,231 - $6,591	27 Added 13.57%	226 $48,000
Q4 2021 Feb 11, 2022	SELL	$223.92 - $287.77 $6,493 - $8,345	-29 Reduced 12.72%	199 $48,000
Q3 2021 Nov 10, 2021	SELL	$282.99 - $369.05 $23,205 - $30,262	-82 Reduced 26.45%	228 $65,000
Q2 2021 Aug 11, 2021	BUY	$259.0 - $414.71 $31,339 - $50,179	121 Added 64.02%	310 $107,000
Q1 2021 May 13, 2021	SELL	$242.95 - $284.63 $6,559 - $7,685	-27 Reduced 12.5%	189 $53,000
Q4 2020 Feb 12, 2021	BUY	$236.26 - $355.63 $472 - $711	2 Added 0.93%	216 $53,000
Q3 2020 Nov 13, 2020	SELL	$264.77 - $305.71 $1,588 - $1,834	-6 Reduced 2.73%	214 $61,000
Q2 2020 Aug 13, 2020	BUY	$258.66 - $342.55 $258 - $342	1 Added 0.46%	220 $59,000
Q1 2020 May 15, 2020	SELL	$268.85 - $341.04 $5,377 - $6,820	-20 Reduced 8.37%	219 $69,000
Q4 2019 Feb 14, 2020	SELL	$220.06 - $304.07 $6,381 - $8,818	-29 Reduced 10.82%	239 $71,000
Q3 2019 Nov 13, 2019	SELL	$217.44 - $243.88 $652 - $731	-3 Reduced 1.11%	268 $62,000
Q2 2019 Jul 09, 2019	SELL	$219.29 - $241.72 $152,625 - $168,237	-696 Reduced 71.98%	271 $63,000
Q1 2019 May 10, 2019	BUY	$216.71 - $338.96 $216 - $338	1 Added 0.1%	967 $229,000
Q4 2018 Feb 13, 2019	BUY	$278.5 - $352.75 $269,031 - $340,756	966 New	966 $291,000

Others Institutions Holding BIIB

# of Institutions

1,049

Shares Held

128M

Call Options Held

1.22M

Put Options Held

1.4M

View Full List

About BIOGEN INC.

Ticker BIIB
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 144,000,992
Market Cap $27.2B
Description
Biogen Inc. discovers, develops, manufactures, and delivers therapies for treating neurological and neurodegenerative diseases. The company offers TECFIDERA, VUMERITY, AVONEX, PLEGRIDY, TYSABRI, and FAMPYRA for multiple sclerosis (MS); SPINRAZA for spinal muscular atrophy; and FUMADERM to treat plaque psoriasis. It also provides BENEPALI, an eta...

More about BIIB

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Zions Bancorporation, N.A., based on Form 13F filings with the SEC.

News

Stay updated on Zions Bancorporation, N.A. with notifications on news.

Account

Zions Bancorporation, N.A. Biogen Inc. Transaction History